“We create a true-to-life environment where cells thrive.”
The Swedish biotech company BioLamina develops and manufactures advanced cell culture solutions. By enabling the development of safe and effective cell and gene therapies, the company aims to help improve the lives of a large part of the world’s population.
Thérese Kallur, Chief Security Officer & Chief Business Development Officer, BioLamina.
BioLamina primarily supports translational researchers in academia and industry by enabling them to culture, expand, and differentiate cells reliably and reproducibly. The company mainly offers Biolaminin® substrates, which mimic the natural environment cells need to function and remain healthy outside the body.
Our newsletter focuses primarily on life science and highlights key players, topics and development within the innovation ecosystem in the Stockholm-Uppsala region.
